BPH Global Ltd (ASX:BP8)
Australia · Delayed Price · Currency is AUD 0.0030
0.00 (0.00%)
Feb 9, 2026, 2:39 PM AEST
BPH Global Revenue
In the fiscal year ending June 30, 2025, BPH Global had annual revenue of 352.38K AUD with 220.44% growth. BPH Global had revenue of 301.44K in the half year ending June 30, 2025.
Revenue
352.38K
Revenue Growth
+220.44%
P/S Ratio
15.78
Revenue / Employee
11.37K
Employees
31
Market Cap
5.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 352.38K | 242.41K | 220.44% |
| Jun 30, 2024 | 109.97K | 109.63K | 32,338.05% |
| Jun 30, 2023 | 339.00 | -493.67K | -99.93% |
| Jun 30, 2022 | 494.01K | -8.00M | -94.19% |
| Jun 30, 2021 | 8.50M | 7.77M | 1,063.19% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 124.04M |
| Little Green Pharma | 38.49M |
| IDT Australia | 19.77M |
| ECS Botanics Holdings | 19.36M |
| Elixinol Wellness | 15.85M |
| Peak Processing | 15.49M |
| Cann Group | 13.25M |
| Epsilon Healthcare | 6.13M |